| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |